Cotreatment With a Novel Phosphoinositide Analogue Inhibitor and Carmustine Enhances Chemotherapeutic Efficacy by Attenuating AKT Activity in Gliomas

Cancer - United States
doi 10.1002/cncr.22248
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Inhibition of Constitutively Activated Phosphoinositide 3-Kinase/Akt Pathway Enhances Antitumor Activity of Chemotherapeutic Agents in Breast Cancer Susceptibility Gene 1-Defective Breast Cancer Cells

Molecular Carcinogenesis
Cancer ResearchMolecular Biology
2012English

Tumor-Targeting Nanodelivery Enhances the Anticancer Activity of a Novel Quinazolinone Analogue

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

TrkB Inhibition by GNF-4256 Slows Growth and Enhances Chemotherapeutic Efficacy in Neuroblastoma Xenografts

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2014English

Tumor Vessel Normalization After Aerobic Exercise Enhances Chemotherapeutic Efficacy

Oncotarget
Oncology
2016English

BIRB796, the Inhibitor of P38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells

PLoS ONE
Multidisciplinary
2013English

Sonoporation by Low‑frequency and Low‑power Ultrasound Enhances Chemotherapeutic Efficacy in Prostate Cancer Cells In�vitro

Oncology Letters
Cancer ResearchOncology
2013English

Novel ADAM-17 Inhibitor ZLDI-8 Enhances the in Vitro and in Vivo Chemotherapeutic Effects of Sorafenib on Hepatocellular Carcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Reduced RKIP Enhances Nasopharyngeal Carcinoma Radioresistance by Increasing ERK and AKT Activity

Oncotarget
Oncology
2016English

Cytotoxic Activity of the Novel Akt Inhibitor, MK-2206, in T-Cell Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy